Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma

Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for... ORIGINAL ARTICLE Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma Lin Yang, MD,*Þ Xiao-ming Zhang, MD,* Bang-xian Tan, MS,Þ Mi Liu, BS,Þ Guo-li Dong, MS,* and Zhao-hua Zhai, MS* ating method, which depended on the results of ultrasound, con- Background: Computed tomographic (CT) perfusion imaging has ventional computed tomography (CT), or magnetic resonance been applied in many clinical areas, but few studies have addressed the imaging, proposed to date, remains much debated, as tumors values of CT perfusion imaging in evaluating the therapeutic response may not decrease in size after chemoembolization despite their of chemoembolization for hepatocellular carcinoma (HCC). 7,8 being nonviable. The lack of accurate estimation of the thera- Objective: To assess the perfusion changes of HCC after transarterial peutic response of liver tumor has hindered the correct treatment chemoembolization, and to investigate the values of CT perfusion im- planning, such as the timing and frequency of repeat chemoem- aging in chemoembolization procedure. bolization, and it has also been difficult to evaluate the efficacy as Methods: Multidetector computed tomographic perfusion imaging was well as prognosis. Gratifyingly, an amendment to the RECIST, performed in 24 patients with HCC 1 week before and 4 weeks http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Computer Assisted Tomography Wolters Kluwer Health

Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma

Loading next page...
 
/lp/wolters-kluwer-health/computed-tomographic-perfusion-imaging-for-the-therapeutic-response-of-WWoj6dV2VG

References (18)

Copyright
Copyright © 2012 by Lippincott Williams & Wilkins
ISSN
0363-8715
eISSN
1532-3145
DOI
10.1097/RCT.0b013e318245c23c
pmid
22446364
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma Lin Yang, MD,*Þ Xiao-ming Zhang, MD,* Bang-xian Tan, MS,Þ Mi Liu, BS,Þ Guo-li Dong, MS,* and Zhao-hua Zhai, MS* ating method, which depended on the results of ultrasound, con- Background: Computed tomographic (CT) perfusion imaging has ventional computed tomography (CT), or magnetic resonance been applied in many clinical areas, but few studies have addressed the imaging, proposed to date, remains much debated, as tumors values of CT perfusion imaging in evaluating the therapeutic response may not decrease in size after chemoembolization despite their of chemoembolization for hepatocellular carcinoma (HCC). 7,8 being nonviable. The lack of accurate estimation of the thera- Objective: To assess the perfusion changes of HCC after transarterial peutic response of liver tumor has hindered the correct treatment chemoembolization, and to investigate the values of CT perfusion im- planning, such as the timing and frequency of repeat chemoem- aging in chemoembolization procedure. bolization, and it has also been difficult to evaluate the efficacy as Methods: Multidetector computed tomographic perfusion imaging was well as prognosis. Gratifyingly, an amendment to the RECIST, performed in 24 patients with HCC 1 week before and 4 weeks

Journal

Journal of Computer Assisted TomographyWolters Kluwer Health

Published: Mar 1, 2012

There are no references for this article.